Juno halts planned sale of Velcade generic in settlement with Millennium, US
Generic drug maker Juno Pharmaceuticals has agreed to stopped planned sales of its cheap version of Millennium Pharmaceuticals anti-cancer medication Velcade in Australia as part of a settlement of its lawsuit alleging two patents covering the drug were invalid.
For information on rights and reprints, contact subscriptions@lawyerly.com.au